🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Theravance Biopharma Inc (TBPH)

NASDAQ
Currency in USD
Disclaimer
8.14
+0.03(+0.37%)
Closed
After Hours
8.140.00(0.00%)
TBPH Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
8.108.20
52 wk Range
7.4411.71
Prev. Close
8.11
Open
8.15
Day's Range
8.1-8.2
52 wk Range
7.44-11.71
Volume
130,011
Average Volume (3m)
401,103
1-Year Change
-9.56%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
TBPH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
13.20
Upside
+62.16%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Theravance Biopharma Inc Company Profile

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company’s product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has licensing and collaboration agreements with Pfizer Inc. for its preclinical skin-selective pan-JAK inhibitor program, as well as Viatris Inc. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.

Employees
99

Compare TBPH to Peers and Sector

Metrics to compare
TBPH
Peers
Sector
Relationship
P/E Ratio
−8.7x−2.4x−0.6x
PEG Ratio
0.080.010.00
Price/Book
2.1x0.7x2.6x
Price / LTM Sales
6.4x1.6x3.1x
Upside (Analyst Target)
35.1%77.8%55.7%
Fair Value Upside
Unlock23.4%6.8%Unlock

People Also Watch

36.20
JHG
+1.09%
21.39
FTRE
+3.78%
70.00
SOLV
+1.97%
4.780
ACTG
+0.63%
16.12
GDS
-0.25%

FAQ

What Is the Theravance Biopharma (TBPH) Stock Price Today?

The Theravance Biopharma stock price today is 8.14

What Stock Exchange Does Theravance Biopharma Trade On?

Theravance Biopharma is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Theravance Biopharma?

The stock symbol for Theravance Biopharma is "TBPH."

What Is the Theravance Biopharma Market Cap?

As of today, Theravance Biopharma market cap is 398.23M.

What is Theravance Biopharma Earnings Per Share?

The Theravance Biopharma EPS is -0.919.

What Is the Next Theravance Biopharma Earnings Date?

Theravance Biopharma will release its next earnings report on Nov 05, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.